Functionally Selective Dopamine D2/D3 Receptor Agonists Comprising an Enyne Moiety

Dopaminergics of types 1 and 2 incorporating a conjugated enyne as an atypical catechol-simulating moiety were synthesized in enantiomerically pure form and investigated for their metabolic stability. Radioligand binding studies indicated high affinity to D2-like receptors. The test compounds were e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2013-06, Vol.56 (12), p.5130-5141
Hauptverfasser: Hiller, Christine, Kling, Ralf C, Heinemann, Frank W, Meyer, Karsten, Hübner, Harald, Gmeiner, Peter
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5141
container_issue 12
container_start_page 5130
container_title Journal of medicinal chemistry
container_volume 56
creator Hiller, Christine
Kling, Ralf C
Heinemann, Frank W
Meyer, Karsten
Hübner, Harald
Gmeiner, Peter
description Dopaminergics of types 1 and 2 incorporating a conjugated enyne as an atypical catechol-simulating moiety were synthesized in enantiomerically pure form and investigated for their metabolic stability. Radioligand binding studies indicated high affinity to D2-like receptors. The test compounds were evaluated for their ability to differentially activate distinct signaling pathways. Measurement of D2L- and D2S-mediated [35S]GTPγS incorporation in the presence of coexpressed Gαo and Gαi subunits showed significantly biased receptor activation for several test compounds. Thus, the 2-azaindolylcarboxamide (S)-2a exhibited substantial functional selectivity for D2S-promoted Go activation over Gi coupling. The most significant bias was determined for the triazolylalkoxy-substituted benzamide (S)-2c that displayed higher potency for Go activation than for Gi coupling at the D2L subtype. Functional selectivity for β-arrestin recruitment over Gi activation was observed for the biphenylcarboxamide (R)-1 and the 2-benzothiophenylcarboxamide (S)-2d, whereas the 2-substituted azaindole (S)-2a preferred β-arrestin recruitment compared to Go coupling.
doi_str_mv 10.1021/jm400520c
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1372696391</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1372696391</sourcerecordid><originalsourceid>FETCH-LOGICAL-a241t-efc31dea23c4802dfac0941d06ed731a90104f3929ca1bf284b7ad855349cad43</originalsourceid><addsrcrecordid>eNo9kE1Lw0AQhhdRbK0e_AOSi-AldnZmmzTH0g8VKkLVc9hsNiUl2Y3ZRMi_d6XV0zszPLwMD2O3HB45IJ8eagEwQ1BnbMx9hmIO4pyNARBDjJBG7Mq5AwAQR7pkI6SYIKF4zHab3qiutEZW1RC860r77VsHK9vIujR-wOmKgp1WuulsGyz21pSuc8HS1k1butLsA2mCtRk8-2pL3Q3X7KKQldM3p5ywz836Y_kcbt-eXpaLbShR8C7UhSKea4mk_LuYF1JBIngOkc5j4jIBDqKgBBMleVbgXGSxzOezGQl_yQVN2MOxt2ntV69dl9alU7qqpNG2dymnGKMkooR79O6E9lmt89R_Xst2SP88eOD-CEjl0oPtW-_DN0D66zf990s_d9RpeQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1372696391</pqid></control><display><type>article</type><title>Functionally Selective Dopamine D2/D3 Receptor Agonists Comprising an Enyne Moiety</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Hiller, Christine ; Kling, Ralf C ; Heinemann, Frank W ; Meyer, Karsten ; Hübner, Harald ; Gmeiner, Peter</creator><creatorcontrib>Hiller, Christine ; Kling, Ralf C ; Heinemann, Frank W ; Meyer, Karsten ; Hübner, Harald ; Gmeiner, Peter</creatorcontrib><description>Dopaminergics of types 1 and 2 incorporating a conjugated enyne as an atypical catechol-simulating moiety were synthesized in enantiomerically pure form and investigated for their metabolic stability. Radioligand binding studies indicated high affinity to D2-like receptors. The test compounds were evaluated for their ability to differentially activate distinct signaling pathways. Measurement of D2L- and D2S-mediated [35S]GTPγS incorporation in the presence of coexpressed Gαo and Gαi subunits showed significantly biased receptor activation for several test compounds. Thus, the 2-azaindolylcarboxamide (S)-2a exhibited substantial functional selectivity for D2S-promoted Go activation over Gi coupling. The most significant bias was determined for the triazolylalkoxy-substituted benzamide (S)-2c that displayed higher potency for Go activation than for Gi coupling at the D2L subtype. Functional selectivity for β-arrestin recruitment over Gi activation was observed for the biphenylcarboxamide (R)-1 and the 2-benzothiophenylcarboxamide (S)-2d, whereas the 2-substituted azaindole (S)-2a preferred β-arrestin recruitment compared to Go coupling.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm400520c</identifier><identifier>PMID: 23730937</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Alkenes - chemistry ; Alkynes - chemistry ; Alkynes - metabolism ; Alkynes - pharmacology ; Animals ; Dopamine Agonists - chemistry ; Dopamine Agonists - metabolism ; Dopamine Agonists - pharmacology ; Drug Stability ; Humans ; Ligands ; Male ; Models, Molecular ; Protein Conformation ; Rats ; Receptors, Dopamine D2 - agonists ; Receptors, Dopamine D2 - chemistry ; Receptors, Dopamine D3 - agonists ; Receptors, Dopamine D3 - chemistry ; Stereoisomerism ; Substrate Specificity</subject><ispartof>Journal of medicinal chemistry, 2013-06, Vol.56 (12), p.5130-5141</ispartof><rights>Copyright © 2013 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm400520c$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm400520c$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23730937$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hiller, Christine</creatorcontrib><creatorcontrib>Kling, Ralf C</creatorcontrib><creatorcontrib>Heinemann, Frank W</creatorcontrib><creatorcontrib>Meyer, Karsten</creatorcontrib><creatorcontrib>Hübner, Harald</creatorcontrib><creatorcontrib>Gmeiner, Peter</creatorcontrib><title>Functionally Selective Dopamine D2/D3 Receptor Agonists Comprising an Enyne Moiety</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Dopaminergics of types 1 and 2 incorporating a conjugated enyne as an atypical catechol-simulating moiety were synthesized in enantiomerically pure form and investigated for their metabolic stability. Radioligand binding studies indicated high affinity to D2-like receptors. The test compounds were evaluated for their ability to differentially activate distinct signaling pathways. Measurement of D2L- and D2S-mediated [35S]GTPγS incorporation in the presence of coexpressed Gαo and Gαi subunits showed significantly biased receptor activation for several test compounds. Thus, the 2-azaindolylcarboxamide (S)-2a exhibited substantial functional selectivity for D2S-promoted Go activation over Gi coupling. The most significant bias was determined for the triazolylalkoxy-substituted benzamide (S)-2c that displayed higher potency for Go activation than for Gi coupling at the D2L subtype. Functional selectivity for β-arrestin recruitment over Gi activation was observed for the biphenylcarboxamide (R)-1 and the 2-benzothiophenylcarboxamide (S)-2d, whereas the 2-substituted azaindole (S)-2a preferred β-arrestin recruitment compared to Go coupling.</description><subject>Alkenes - chemistry</subject><subject>Alkynes - chemistry</subject><subject>Alkynes - metabolism</subject><subject>Alkynes - pharmacology</subject><subject>Animals</subject><subject>Dopamine Agonists - chemistry</subject><subject>Dopamine Agonists - metabolism</subject><subject>Dopamine Agonists - pharmacology</subject><subject>Drug Stability</subject><subject>Humans</subject><subject>Ligands</subject><subject>Male</subject><subject>Models, Molecular</subject><subject>Protein Conformation</subject><subject>Rats</subject><subject>Receptors, Dopamine D2 - agonists</subject><subject>Receptors, Dopamine D2 - chemistry</subject><subject>Receptors, Dopamine D3 - agonists</subject><subject>Receptors, Dopamine D3 - chemistry</subject><subject>Stereoisomerism</subject><subject>Substrate Specificity</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1Lw0AQhhdRbK0e_AOSi-AldnZmmzTH0g8VKkLVc9hsNiUl2Y3ZRMi_d6XV0zszPLwMD2O3HB45IJ8eagEwQ1BnbMx9hmIO4pyNARBDjJBG7Mq5AwAQR7pkI6SYIKF4zHab3qiutEZW1RC860r77VsHK9vIujR-wOmKgp1WuulsGyz21pSuc8HS1k1butLsA2mCtRk8-2pL3Q3X7KKQldM3p5ywz836Y_kcbt-eXpaLbShR8C7UhSKea4mk_LuYF1JBIngOkc5j4jIBDqKgBBMleVbgXGSxzOezGQl_yQVN2MOxt2ntV69dl9alU7qqpNG2dymnGKMkooR79O6E9lmt89R_Xst2SP88eOD-CEjl0oPtW-_DN0D66zf990s_d9RpeQ</recordid><startdate>20130627</startdate><enddate>20130627</enddate><creator>Hiller, Christine</creator><creator>Kling, Ralf C</creator><creator>Heinemann, Frank W</creator><creator>Meyer, Karsten</creator><creator>Hübner, Harald</creator><creator>Gmeiner, Peter</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20130627</creationdate><title>Functionally Selective Dopamine D2/D3 Receptor Agonists Comprising an Enyne Moiety</title><author>Hiller, Christine ; Kling, Ralf C ; Heinemann, Frank W ; Meyer, Karsten ; Hübner, Harald ; Gmeiner, Peter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a241t-efc31dea23c4802dfac0941d06ed731a90104f3929ca1bf284b7ad855349cad43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Alkenes - chemistry</topic><topic>Alkynes - chemistry</topic><topic>Alkynes - metabolism</topic><topic>Alkynes - pharmacology</topic><topic>Animals</topic><topic>Dopamine Agonists - chemistry</topic><topic>Dopamine Agonists - metabolism</topic><topic>Dopamine Agonists - pharmacology</topic><topic>Drug Stability</topic><topic>Humans</topic><topic>Ligands</topic><topic>Male</topic><topic>Models, Molecular</topic><topic>Protein Conformation</topic><topic>Rats</topic><topic>Receptors, Dopamine D2 - agonists</topic><topic>Receptors, Dopamine D2 - chemistry</topic><topic>Receptors, Dopamine D3 - agonists</topic><topic>Receptors, Dopamine D3 - chemistry</topic><topic>Stereoisomerism</topic><topic>Substrate Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hiller, Christine</creatorcontrib><creatorcontrib>Kling, Ralf C</creatorcontrib><creatorcontrib>Heinemann, Frank W</creatorcontrib><creatorcontrib>Meyer, Karsten</creatorcontrib><creatorcontrib>Hübner, Harald</creatorcontrib><creatorcontrib>Gmeiner, Peter</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hiller, Christine</au><au>Kling, Ralf C</au><au>Heinemann, Frank W</au><au>Meyer, Karsten</au><au>Hübner, Harald</au><au>Gmeiner, Peter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Functionally Selective Dopamine D2/D3 Receptor Agonists Comprising an Enyne Moiety</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2013-06-27</date><risdate>2013</risdate><volume>56</volume><issue>12</issue><spage>5130</spage><epage>5141</epage><pages>5130-5141</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>Dopaminergics of types 1 and 2 incorporating a conjugated enyne as an atypical catechol-simulating moiety were synthesized in enantiomerically pure form and investigated for their metabolic stability. Radioligand binding studies indicated high affinity to D2-like receptors. The test compounds were evaluated for their ability to differentially activate distinct signaling pathways. Measurement of D2L- and D2S-mediated [35S]GTPγS incorporation in the presence of coexpressed Gαo and Gαi subunits showed significantly biased receptor activation for several test compounds. Thus, the 2-azaindolylcarboxamide (S)-2a exhibited substantial functional selectivity for D2S-promoted Go activation over Gi coupling. The most significant bias was determined for the triazolylalkoxy-substituted benzamide (S)-2c that displayed higher potency for Go activation than for Gi coupling at the D2L subtype. Functional selectivity for β-arrestin recruitment over Gi activation was observed for the biphenylcarboxamide (R)-1 and the 2-benzothiophenylcarboxamide (S)-2d, whereas the 2-substituted azaindole (S)-2a preferred β-arrestin recruitment compared to Go coupling.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>23730937</pmid><doi>10.1021/jm400520c</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2013-06, Vol.56 (12), p.5130-5141
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_1372696391
source MEDLINE; American Chemical Society Journals
subjects Alkenes - chemistry
Alkynes - chemistry
Alkynes - metabolism
Alkynes - pharmacology
Animals
Dopamine Agonists - chemistry
Dopamine Agonists - metabolism
Dopamine Agonists - pharmacology
Drug Stability
Humans
Ligands
Male
Models, Molecular
Protein Conformation
Rats
Receptors, Dopamine D2 - agonists
Receptors, Dopamine D2 - chemistry
Receptors, Dopamine D3 - agonists
Receptors, Dopamine D3 - chemistry
Stereoisomerism
Substrate Specificity
title Functionally Selective Dopamine D2/D3 Receptor Agonists Comprising an Enyne Moiety
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A03%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Functionally%20Selective%20Dopamine%20D2/D3%20Receptor%20Agonists%20Comprising%20an%20Enyne%20Moiety&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Hiller,%20Christine&rft.date=2013-06-27&rft.volume=56&rft.issue=12&rft.spage=5130&rft.epage=5141&rft.pages=5130-5141&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/jm400520c&rft_dat=%3Cproquest_pubme%3E1372696391%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1372696391&rft_id=info:pmid/23730937&rfr_iscdi=true